TG Therapeutics | TGTX - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
AbbVie USD 4.73B 1.08B 2026-03
Alaunos Therapeutics USD -1.01M 175K 2026-03
Amgen USD 3.83B 130M 2026-03
Ardelyx USD 5.1M 431K 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Biogen USD 514.3M 128.8M 2026-03
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Curis USD -7.88M 4.63M 2025-12
Gilead Sciences USD 2.68B 284M 2026-03
J&J USD 6.62B 1.03B 2026-03
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Novartis USD 4.24B 171M 2026-03
Novavax USD 20.94M 100.32M 2025-12
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
TG Therapeutics USD 34.8M 15.7M 2026-03
Verastem USD -41.48M 23.2M 2025-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03